Skip to main content
. 2023 Aug 7;13(8):1227. doi: 10.3390/biom13081227

Figure 1.

Figure 1

Literature evidence map for chaperones in lysosomal storage disorders. Orange circles = preclinical studies. Blue squares = clinical studies. Closed squares = one study; open square = 2 articles reporting data from the same study. a One citation reported an analysis including both chaperones N-butyl-deoxynojirimycin (NB-DNJ) and 1-deoxynojirimycin (DNJ), counted twice. Abbreviations: DGJ, 1-deoxygalactonojirimycin/migalastat; DNJ, 1-deoxynojirimycin; NB-DNJ, N-butyl-deoxynojirimycin/miglustat; NN-DNJ, N-Nonyldeoxynojirimycin; NOEV, N-octyl-4-epi-beta-valienamine; NPC, Niemann–Pick Disease Type C; MPSI, Muco-polysaccharidosis 1.